|
|
 Previous Article | Table of Contents | Next Article 
Characterization of Signal Transduction Pathways in Human Bone Marrow Endothelial Cells
Zhong-Ying Liu,
Ramesh K. Ganju,
Jian-Feng Wang,
Karin Schweitzer,
Babette Weksler,
Shalom Avraham, and
Jerome E. Groopman
From the Divisions of Experimental Medicine and Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; the Department of Haematology, Free University Hospital, Amsterdam, The Netherlands; and the Division of Hematology/Oncology, Cornell University Medical College, New York, NY.
Human bone marrow endothelial cells immortalized with the T antigen of SV40 (TrHBMEC) have previously been characterized by us with regard to their properties that are similar to primary marrow endothelial cells and their utility as a model system. We now report that TrHBMEC express a recently discovered signal transduction molecule termed RAFTK (related adhesion focal tyrosine kinase), also called Pyk2 or CAK- . RAFTK, the second member of the focal adhesion kinase (FAK) family, is known to be activated in response to calcium flux in neuronal cells and integrin stimulation in megakaryocytes and B cells. We have studied the effects of cytokines on RAFTK activation in TrHBMEC. Treatment of TrHBMEC with the vascular endothelial growth factor (VEGF ), as well as the VEGF-related protein (VRP), the recently identified ligand for the FLT-4 receptor, resulted in enhanced tyrosine phosphorylation of RAFTK. Similar changes in RAFTK phosphorylation were observed upon stimulation of TrHBMEC with basic fibroblast growth factor (bFGF ) or oncostatin M (OSM). Stimulation of these cells with growth factors also resulted in an increase in RAFTK activity and the c-Jun NH2 -terminal kinase (JNK). RAFTK coimmunoprecipitated with the cytoskeletal protein paxillin through its C-terminal proline-rich domain in TrHBMEC. These results suggest that, in marrow endothelium, activation of RAFTK by VEGF, VRP, OSM, and bFGF represents a new element in the signal transduction pathways used by these growth factors and likely acts to coordinate signaling from their surface receptors to the cytoskeleton, thereby modulating cell growth and function.
Blood, Vol. 90 No. 6 (September 15), 1997:
pp. 2253-2259
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
P. Rocic, C. Kolz, R. Reed, B. Potter, and W. M. Chilian
Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth
Am J Physiol Heart Circ Physiol,
June 1, 2007;
292(6):
H2729 - H2736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Wang, J. Chang, K.-D. Chen, S. Li, J. Y.-S. Li, C. Wu, and S. Chien
Selective adapter recruitment and differential signaling networks by VEGF vs. shear stress
PNAS,
May 22, 2007;
104(21):
8875 - 8879.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Conway, N. Petrovic, Z. Li, W. Heston, D. Wu, and L. H. Shapiro
Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction.
Mol. Cell. Biol.,
July 1, 2006;
26(14):
5310 - 5324.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Zhang, J. F. Wang, B. Chandran, K. Persaud, B. Pytowski, J. Fingeroth, and J. E. Groopman
Kaposi's Sarcoma-associated Herpesvirus Activation of Vascular Endothelial Growth Factor Receptor 3 Alters Endothelial Function and Enhances Infection
J. Biol. Chem.,
July 15, 2005;
280(28):
26216 - 26224.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Kumar, A. I. Miller, and P. J. Polverini
p38 MAPK Mediates {gamma}-Irradiation-induced Endothelial Cell Apoptosis, and Vascular Endothelial Growth Factor Protects Endothelial Cells through the Phosphoinositide 3-Kinase-Akt-Bcl-2 Pathway
J. Biol. Chem.,
October 8, 2004;
279(41):
43352 - 43360.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. B. Beleslin-Cokic, V. P. Cokic, X. Yu, B. B. Weksler, A. N. Schechter, and C. T. Noguchi
Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells
Blood,
October 1, 2004;
104(7):
2073 - 2080.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Rodriguez-Fernandez, L. Sanchez-Martin, C. A. de Frutos, D. Sancho, M. Robinson, F. Sanchez-Madrid, and C. Cabanas
LFA-1 integrin and the microtubular cytoskeleton are involved in the Ca2+-mediated regulation of the activity of the tyrosine kinase PYK2 in T cells
J. Leukoc. Biol.,
March 1, 2002;
71(3):
520 - 530.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Zachary
Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor
Am J Physiol Cell Physiol,
June 1, 2001;
280(6):
C1375 - C1386.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Zachary and G. Gliki
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family
Cardiovasc Res,
February 16, 2001;
49(3):
568 - 581.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Klasa, A. F. List, and B. D. Cheson
Rational Approaches to Design of Therapeutics Targeting Molecular Markers
Hematology,
January 1, 2001;
2001(1):
443 - 462.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Rousseau, F. Houle, H. Kotanides, L. Witte, J. Waltenberger, J. Landry, and J. Huot
Vascular Endothelial Growth Factor (VEGF)-driven Actin-based Motility Is Mediated by VEGFR2 and Requires Concerted Activation of Stress-activated Protein Kinase 2 (SAPK2/p38) and Geldanamycin-sensitive Phosphorylation of Focal Adhesion Kinase
J. Biol. Chem.,
March 31, 2000;
275(14):
10661 - 10672.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Tang, Z. J. Zhao, E. J. Landon, and T. Inagami
Regulation of Calcium-sensitive Tyrosine Kinase Pyk2 by Angiotensin II in Endothelial Cells. ROLES OF Yes TYROSINE KINASE AND TYROSINE PHOSPHATASE SHP-2
J. Biol. Chem.,
March 17, 2000;
275(12):
8389 - 8396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Benbernou, K. Muegge, and S. K. Durum
Interleukin (IL)-7 Induces Rapid Activation of Pyk2, Which Is Bound to Janus Kinase 1 and IL-7Ralpha
J. Biol. Chem.,
March 15, 2000;
275(10):
7060 - 7065.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Munshi, R. K. Ganju, S. Avraham, E. A. Mesri, and J. E. Groopman
Kaposi's Sarcoma-associated Herpesvirus-encoded G Protein-coupled Receptor Activation of c-Jun Amino-terminal Kinase/Stress-activated Protein Kinase and Lyn Kinase Is Mediated by Related Adhesion Focal Tyrosine Kinase/Proline-rich Tyrosine Kinase 2
J. Biol. Chem.,
November 5, 1999;
274(45):
31863 - 31867.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Li, R. C. Dy, W. G. Cance, L. M. Graves, and H. S. Earp
Interactions between Two Cytoskeleton-associated Tyrosine Kinases: Calcium-dependent Tyrosine Kinase and Focal Adhesion Tyrosine Kinase
J. Biol. Chem.,
March 26, 1999;
274(13):
8917 - 8924.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Armesilla, E. Lorenzo, P. Gomez del Arco, S. Martinez-Martinez, A. Alfranca, and J. M. Redondo
Vascular Endothelial Growth Factor Activates Nuclear Factor of Activated T Cells in Human Endothelial Cells: a Role for Tissue Factor Gene Expression
Mol. Cell. Biol.,
March 1, 1999;
19(3):
2032 - 2043.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. K. Ganju, S. A. Brubaker, J. Meyer, P. Dutt, Y. Yang, S. Qin, W. Newman, and J. E. Groopman
The alpha -Chemokine, Stromal Cell-derived Factor-1alpha , Binds to the Transmembrane G-protein-coupled CXCR-4 Receptor and Activates Multiple Signal Transduction Pathways
J. Biol. Chem.,
September 4, 1998;
273(36):
23169 - 23175.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I Krause, Z Blumenfeld, M Malchinsky, S Cohen, M Blank, A Eldor, B Weksler, K Schweitzer, and Y Shoenfeld
Anti-endothelial cell antibodies in the sera of hyperprolactinemic women
Lupus,
July 1, 1998;
7(6):
377 - 382.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. K. Ganju, P. Dutt, L. Wu, W. Newman, H. Avraham, S. Avraham, and J. E. Groopman
beta -Chemokine Receptor CCR5 Signals Via the Novel Tyrosine Kinase RAFTK
Blood,
February 1, 1998;
91(3):
791 - 797.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
